Xcelerating the growth, success and full potential of MedTech development and Healthcare Delivery with End to End control.
Xcelerate seeks to acquire rather than develop its technology / healthcare delivery. We understand that engineering advancements in non-medical fields often have unrealized applications in medical technology & clinical care and the silos existing between advanced engineering and medicine have been poorly bridged. Xcelerate is unique in that it was designed from inception to span the divide between initial non-medical engineering advancements and its application to clinical care.
$XCRT We have filed 2023 Annual Report! Find it on EDGAR, OTCmarket & company website:
https://xcelerate.global/xcelerate-inc-announces-that-it-has-filed-its-2023-annual-report/
$XCRT Our subsidiary, ESN Group, announced last week that Ceramedx® skincare products are now available on the @AAFES online store (), offering tax-free savings to over 20 million members.
Read more: https://xcelerate.global/xcelerate-inc-announces-that-esn-group-inc-has-gone-live-on-the-army-air-force-exchange-service-online-exchange/
More updates coming!
$XCRT We've hired Darrow Associates (https://www.darrowir.com/) to connect with the broader financial community and spread the awareness about Xcelerate's growth opportunities.
Read full Press release
https://www.otcmarkets.com/stock/XCRT/news/Xcelerate-Inc-Engages-Leading-Investor-Relations-Firm-Darrow-Associates-to-Enhance-Capital-Markets-Presence?id=434219
#investorrelations #financialcommunity #StockMarket
